...
首页> 外文期刊>Cell cycle >P-TEFb as a target to reactivate latent HIV: Two Brds are now in hand
【24h】

P-TEFb as a target to reactivate latent HIV: Two Brds are now in hand

机译:P-TEFb作为重新激活潜在HIV的目标:现在有两个Brds

获取原文
获取原文并翻译 | 示例
           

摘要

P-TEFb is a protein kinase required for RNA polymerase II transcriptional elongation of most, if not all, mammalian protein-coding genes. P-TEFb is believed to be a therapeutic target for cancer, and inhibitors of P-TEFb are currently being evaluated in clinical trials. Additionally, P-TEFb has potential as a therapeutic target for HIV infection, as transcriptional elongation of the integrated virus is dependent upon the viral Tat protein's recruitment of P-TEFb to the TAR RNA element at the 5' end of nascent viral transcripts.
机译:P-TEFb是大多数(如果不是全部)哺乳动物编码基因的RNA聚合酶II转录延伸所需的蛋白激酶。据信P-TEFb是癌症的治疗靶标,目前正在临床试验中评估P-TEFb的抑制剂。另外,P-TEFb有潜力作为HIV感染的治疗靶标,因为整合病毒的转录伸长取决于病毒Tat蛋白将P-TEFb募集到新生病毒转录本5'末端的TAR RNA元件上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号